Showing results (121-130 of 197) with videos related to

Sort By:
Pageof 20
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 18, 2013
Item-level psychometric properties for a new patient-reported psoriasis symptom diaryBruce E Strober, Judit Nyirady, Usha G Mallya, et al.
Advances in Therapy|November 22, 2019
Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated AnalysisGerd R Burmester, Kenneth B Gordon, James T Rosenbaum, et al.
Archives of Dermatology|June 22, 2005
Uncovering histologic criteria with prognostic significance in toxic epidermal necrolysisAdam M Quinn, Kimberly Brown, Brian K Bonish, et al.
Archives of Dermatology|February 21, 2007
National Psoriasis Foundation clinical consensus on disease severityDavid M Pariser, Jerry Bagel, Joel M Gelfand, et al.
The Journal of Investigative Dermatology. Symposium Proceedings|October 31, 2006
Lessons learned from psoriatic plaques concerning mechanisms of tissue repair, remodeling, and inflammationBrian J Nickoloff, Brian K Bonish, Deborah J Marble, et al.
American Journal of Clinical Dermatology|September 10, 2020
Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 StudyKristian Reich, April W Armstrong, Peter Foley, et al.
Journal of the American Academy of Dermatology|March 9, 2025
Effect of spesolimab on sustained disease control in patients with generalized pustular psoriasis: Post hoc analysis of the EFFISAYIL 2 studyKenneth B Gordon, Matthias Augustin, Jonathan Barker, et al.
Journal of the American Academy of Dermatology|October 11, 2017
Poor early response to methotrexate portends inadequate long-term outcomes in patients with moderate-to-severe psoriasis: Evidence from 2 phase 3 clinical trialsKenneth B Gordon, Keith A Betts, Murali Sundaram, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|December 11, 2002
Evaluation of tissue-engineered skin (human skin substitute) and secondary intention healing in the treatment of full thickness wounds after Mohs micrographic or excisional surgerySharon Gohari, Charles Gambla, Mary Healey, et al.
JAMA|December 18, 2003
Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trialKenneth B Gordon, Kim A Papp, Tiffani K Hamilton, et al.
Pageof 20